Skip to main content
Clinical Trials/CTRI/2022/02/040296
CTRI/2022/02/040296
Not yet recruiting
未知

A controlled randomized study to evaluate the effect of probiotic on uremic solutes,inflammatory status and oxidative stress in chronic kidney disease subjects - PRO-URE-CKD

Dr Vandana Godella0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: N189- Chronic kidney disease, unspecified
Sponsor
Dr Vandana Godella
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Vandana Godella

Eligibility Criteria

Inclusion Criteria

  • 1\.Either gender \>18 to \<65 years (both inclusive)
  • 2\.Subjects diagnosed with CKD and have been stable for at least 3 months
  • 3\.Serum creatinine levels greater than 2\.5 mg/dL at the time of screening.
  • 4\. Ability to comprehend the full nature and purpose of the study, including possible risks and adverse events; ability to co\-operate with the Investigator and to comply with the requirements of the entire study
  • 5\. Willing to sign the written informed consent prior to inclusion in the study at the time of screening.

Exclusion Criteria

  • 1\.Pregnant or Nursing women,
  • 2\.Antibiotic treatment at the time of screening or within 14 days before screening
  • 3\.H/o of positive serologic test for HIV, hepatitis B surface antigen (HBsAg); or Hepatitis C in the last 6 months.
  • 4\.Active dependency on controlled substances and alcohol
  • 5\.Administration of an investigational drug either currently or within 30 days of screening.
  • 6\.Active addictive drug or alcohol use or dependence that, in the opinion of the investigator, would interfere with adherence to study requirements or assessment.
  • 7\.Any illness or condition that in the opinion of the investigator may affect the safety of the participant or the evaluation of any study endpoint.
  • 8\.Pre\-existing cardiac or pulmonary or hepatic or neurological co\-morbidities which in the judgement of the Nephrologist would interfere with the study.
  • 9\.Subjects with social conditions or medical debilitating disease/disorder, which, in the judgment of the investigator, would interfere with or serve as a contraindication to adherence to the study protocol or ability to give informed consent or affect overall prognosis of the Subject.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
ignocaine infusion to reduce propofol consumption in laparoscopic cholecystectomy
JPRN-UMIN000042101Manipal Hospitlals, Old airport road ,Bangalore40
Recruiting
Not Applicable
Will prophylactic antibiotics in out of hospital cardiac arrest survivors receiving targeted temperature management prevent poor outcomesOut of hospital cardiac arrestCirculatory System
ISRCTN12258520niversity Health Network50
Recruiting
Phase 3
A study to observe if probiotics supplementation is helpful in atopic dermatitis childreHealth Condition 1: null- Patients of atopic dermatitis but who have chronic illness and are immunosuppressive are not recruited in the study.
CTRI/2017/08/009236PGIMER Chandigarh
Completed
Phase 2
Effects of vitamin D and calcium on bone and falls in an elderly population of Australian women selected for their history of fallingFalls and bone structure in elderly Australian womenInjuries and Accidents - Other injuries and accidents
ACTRN12606000331538Australian National Health and Medical Research Council294
Not yet recruiting
Phase 2
Protein intake metabolic effects studyBone structure of elderly healthy womenMuscle mass of elderly healthy womenRenal function of elderly healthy womenCardiovascular risk factors of elderly healthy womenBody composition of elderly healthy womenMusculoskeletal - Normal musculoskeletal and cartilage development and functionCardiovascular - Normal development and function of the cardiovascular systemRenal and Urogenital - Normal development and function of male and female renal and urogenital system
ACTRN12607000163404A Professor RL Prince220